Literature DB >> 19605938

Bacterial secretion systems with an emphasis on the chlamydial Type III secretion system.

Delphine Sylvie Anne Beeckman1, Daisy C G Vanrompay.   

Abstract

Numerous bacterial proteins exert their function outside the prokaryotic cell. To this end, both Gram-negative and Gram-positive bacteria have evolved specialized mechanisms to transport their proteins to the bacterial supernatant or host cell cytoplasm, so called secretion systems. These different strategies will be briefly discussed, followed by an in depth description of the Type III secretion system, an efficient molecular syringe assisting Gram-negative bacteria in entrance, growth and survival in eukaryotic host cells. Topics addressed include classification and role of multiple Type III secretion systems, the mechanism of protein translocation into the host cell as well as substrate recognition and chaperoning. Chlamydiales have also been found to encode a Type III secretion system and associated effector proteins. In contrast to the genetic organization in other bacteria, the encoding genes are scattered throughout the genome. To date, no structural information is available on the chlamydial Type III secretion system. We therefore propose a model of the chlamydial Type III secretion system and summarize current knowledge on the role of Type III secretion in the different stages of the chlamydial developmental cycle.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19605938

Source DB:  PubMed          Journal:  Curr Issues Mol Biol        ISSN: 1467-3037            Impact factor:   2.081


  31 in total

Review 1.  Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria.

Authors:  Daniela Büttner
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Divergent Co-occurrence Patterns and Assembly Processes Structure the Abundant and Rare Bacterial Communities in a Salt Marsh Ecosystem.

Authors:  Shicong Du; Francisco Dini-Andreote; Nan Zhang; Chunling Liang; Zhiyuan Yao; Huajun Zhang; Demin Zhang
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

3.  Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms.

Authors:  Hector A Saka; J Will Thompson; Yi-Shan Chen; Yadunanda Kumar; Laura G Dubois; M Arthur Moseley; Raphael H Valdivia
Journal:  Mol Microbiol       Date:  2011-11-07       Impact factor: 3.501

4.  Chlamydia trachomatis Slc1 is a type III secretion chaperone that enhances the translocation of its invasion effector substrate TARP.

Authors:  Amanda J Brinkworth; Denise S Malcolm; António T Pedrosa; Katarzyna Roguska; Sevanna Shahbazian; James E Graham; Richard D Hayward; Rey A Carabeo
Journal:  Mol Microbiol       Date:  2011-09-02       Impact factor: 3.501

Review 5.  Rho GTPases as pathogen targets: Focus on curable sexually transmitted infections.

Authors:  Cristián A Quintero; Julián Gambarte Tudela; María T Damiani
Journal:  Small GTPases       Date:  2015-05-29

Review 6.  Assembly, structure, function and regulation of type III secretion systems.

Authors:  Wanyin Deng; Natalie C Marshall; Jennifer L Rowland; James M McCoy; Liam J Worrall; Andrew S Santos; Natalie C J Strynadka; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2017-04-10       Impact factor: 60.633

7.  Dual transcriptional profiling of a bacterial/fungal confrontation: Collimonas fungivorans versus Aspergillus niger.

Authors:  Francesca Mela; Kathrin Fritsche; Wietse de Boer; Johannes A van Veen; Leo H de Graaff; Marlies van den Berg; Johan H J Leveau
Journal:  ISME J       Date:  2011-05-26       Impact factor: 10.302

8.  Unity in variety--the pan-genome of the Chlamydiae.

Authors:  Astrid Collingro; Patrick Tischler; Thomas Weinmaier; Thomas Penz; Eva Heinz; Robert C Brunham; Timothy D Read; Patrik M Bavoil; Konrad Sachse; Simona Kahane; Maureen G Friedman; Thomas Rattei; Garry S A Myers; Matthias Horn
Journal:  Mol Biol Evol       Date:  2011-06-20       Impact factor: 16.240

9.  Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infection.

Authors:  Shanta Raj Bhattarai; So Young Yoo; Seung-Wuk Lee; Deborah Dean
Journal:  Biomaterials       Date:  2012-04-09       Impact factor: 12.479

Review 10.  Chlamydial intracellular survival strategies.

Authors:  Robert J Bastidas; Cherilyn A Elwell; Joanne N Engel; Raphael H Valdivia
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.